Search results for "marker"

showing 10 items of 3799 documents

Predicting efficacy and toxicity in the era of targeted therapy: focus on anti-EGFR and anti-VEGF molecules

2011

The treatment of solid malignancies includes various target drugs, such as monoclonal antibodies and tyrosine kinase inhibitors, which exert their effect alone or in combination with chemotherapy. The main part of these molecules have a target on proteins of EGFR and VEGF pathways. The particular toxicity profile and the financial impact, deriving from the application of these agents in cancer treatment, prompted a lot of researches to define predictive factors of their efficacy. Various biomarker were identified among the components of the targeted pathways. However just few studies allowed to identify specific factors to predict the toxicity of these drugs. In this review EGFR and VEGF-re…

Vascular Endothelial Growth Factor Amedicine.drug_classSettore MED/06 - Oncologia Medicamedicine.medical_treatmentClinical BiochemistryAngiogenesis InhibitorsAntineoplastic AgentsPharmacologyMonoclonal antibodyTargeted therapyAntineoplastic AgentNeoplasmsProtein-Tyrosine KinasemedicineHumansAngiogenesis Inhibitors; Antibodies Monoclonal; Antineoplastic Agents; Humans; Neoplasms; Protein-Tyrosine Kinases; Receptor Epidermal Growth Factor; Treatment Outcome; Vascular Endothelial Growth Factor ATarget therapyPharmacologyAnti vegfChemotherapybusiness.industryAntibodies MonoclonalProtein-Tyrosine KinasesErbB ReceptorsTreatment OutcomeToxicityCancer researchBiomarker (medicine)NeoplasmReceptor Epidermal Growth FactorbusinessTyrosine kinaseAngiogenesis InhibitorHuman
researchProduct

Kawasaki disease in Sicily: clinical description and markers of disease severity

2016

Background: Kawasaki disease (KD) is an acute systemic vasculitis of small and middle size arteries; 15-25 % of untreated patients and 5 % of patients treated with intravenous immunoglobulin (IVIG) develop coronary artery lesions (CAL). Many studies tried to find the most effective treatment in the management of resistant KD and to select the risk factors for CAL. Our data are assessed on children from west Sicily, characterized by a genetic heterogeneity. Methods: We studied the clinical data of 70 KD Sicilian children (36 males: 51 %; 34 females: 49 %), analysed retrospectively, including: demographic and laboratory parameters; echocardiographic findings at diagnosis, at 2, 6 and 8 weeks,…

VasculitisMaleVasculitimedicine.medical_specialtyCardiovascular Disease; Kawasaki Disease; Small Vessel Vasculitis; Vasculitis030204 cardiovascular system & hematologyMucocutaneous Lymph Node SyndromeSeverity of Illness IndexSmall Vessel Vasculitis03 medical and health sciencesSettore MED/38 - Pediatria Generale E Specialistica0302 clinical medicineDisease severity030225 pediatricshemic and lymphatic diseasesCardiovascular DiseaseMedicineEffective treatmentHumansKawasaki DiseaseSicilyCardiovascular Disease; Kawasaki Disease; Small Vessel Vasculitis; Vasculitis; Pediatrics Perinatology and Child HealthRetrospective Studiesbiologybusiness.industryGenetic heterogeneityResearchmedicine.diseaseDermatologySmall Vessel Vasculitimedicine.anatomical_structureEchocardiographyChild PreschoolPediatrics Perinatology and Child HealthImmunologybiology.proteinKawasaki diseaseFemaleAntibodybusinessVasculitisBiomarkersSystemic vasculitisArteryItalian Journal of Pediatrics
researchProduct

Interaction of endothelial cells and neutrophilsin vitro: kinetics of thrombomodulin, intercellular adhesion molecule-1 (ICAM-1), E-selectin, and vas…

1999

SUMMARYRecently markers of endothelial cell activation or injury gained increasing interest as serological parameters of disease activation in vasculitides. Among these, soluble serum thrombomodulin, ICAM-1, VCAM-1 and E-selectin are of particular interest. However, only thrombomodulin showed the expected close correlation. The objective of this study was to investigate in vitro the kinetics of these endothelial cell receptors after interaction of unstimulated or cytokine-activated polymorphonuclear neutrophils (PMN) and endothelial cells in order to find evidence explaining these different clinical findings. Over the time period of up to 48 h of incubation the kinetics of thrombomodulin, I…

VasculitisNeutrophilsThrombomodulinImmunologyIntercellular Adhesion Molecule-1Vascular Cell Adhesion Molecule-1BiologyThrombomodulinAutoimmune Diseaseschemistry.chemical_compoundCell–cell interactionE-selectinHumansImmunology and AllergyVascular DiseasesVCAM-1ICAM-1Cell adhesion moleculeIntercellular Adhesion Molecule-1Coculture TechniquesEndothelial stem cellKineticsSolubilitychemistryImmunologycardiovascular systembiology.proteinEndothelium VascularE-SelectinBiomarkersClinical and Experimental Immunology
researchProduct

Anti-ETAR and suPAR as markers of disease activity in renal ANCA-associated vasculitis.

2020

Purpose In anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), there is a lack of reliable biomarkers of disease activity. The aim of the study was to evaluate soluble urokinase plasminogen activator receptor (suPAR) and anti-endothelin-1 type A receptor (anti-ETAR) antibodies levels in active phase and remission of AAV. Patients and methods We enrolled 60 patients (median age 63.0 years) with renal AAV into this study. Plasma suPAR, urine suPAR (expressed as urine suPAR/creatinine ratio) and serum anti-ETAR antibodies were assayed by ELISA. Disease activity was assessed using Birmingham Vasculitis Activity Score (BVAS) and patients were divided into 2 subgroups based o…

Vasculitismedicine.medical_specialtyBirmingham Vasculitis Activity ScoreAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisUrineKidneyGastroenterologysuPARAntibodies Antineutrophil CytoplasmicReceptors Urokinase Plasminogen Activatorchemistry.chemical_compoundInternal medicineMedicineHumansReceptorCreatinineKidneybiologybusiness.industryANCAGeneral MedicineMiddle Agedmedicine.diseaseReceptor Endothelin Amedicine.anatomical_structurechemistrySuPARbiology.proteinAntibodybusinessVasculitisBiomarkersAdvances in medical sciences
researchProduct

Genetic diversity and population structure of Sicilian sheep breeds using microsatellite markers

2012

Abstract Genetic diversity studies in domestic animals aim at evaluating genetic variation within and across breeds mainly for conservation purposes. In Sicily, dairy sheep production represents an important resource for hilly and mountain areas economy. Their milk is used for the production of traditional raw milk cheeses, sometimes protected designation of origin (PDO) cheeses. In some cases, the quality of these products is linked to a specific breed, i.e. mono-breed labelled cheeses and it is therefore important to be able to distinguish the milk of a breed from that of others, in order to guarantee both the consumer and the breed itself. In order to investigate the genetic structure an…

Veterinary medicineGenetic diversitySicilian sheep breed Microsatellite markers Genetic diversity Population structurebiologybusiness.industryBarbarescabiology.organism_classificationBreedBiotechnologySettore AGR/17 - Zootecnica Generale E Miglioramento GeneticoFood AnimalsGenetic variationGenetic structureAnimal Science and ZoologySardaGenetic variabilitybusinessInbreedingSmall Ruminant Research
researchProduct

Application of microsatellite markers as potential tools for traceability of Girgentana goat breed dairy products

2015

In livestock, breed assignment may play a key role in the certification of products linked to specific breeds. Traceability of farm animals and authentication of their products can contribute to improve breed profitability and sustainability of animal productions with significant impact on the rural economy of particular geographic areas and on breed and biodiversity conservation. With the goal of developing a breed genetic traceability system for Girgentana dairy products, the aim of this study was to identify specific microsatellite markers able to discriminate among the most important Sicilian dairy goat breeds, in order to detect possible adulteration in Girgentana dairy products. A tot…

Veterinary medicineTraceabilityRural economybusiness.industryBreed genetic traceabilityMolecular markersBiologyGirgentana goat dairy productBreedGirgentana goat breedBiotechnologySettore AGR/17 - Zootecnica Generale E Miglioramento GeneticoBiodiversity conservationBreed genetic traceability; Girgentana goat dairy products; Molecular markersMicrosatelliteDna poolsLivestockbusinessFood ScienceFood Research International
researchProduct

Relationship between beta lactoglobulin and subclinical mastitis in Valle del Belice sheep breed

2010

The objective of the following research was to determine the effect of LGB genotypes on subclinical mastitis in Valle del Belice dairy sheep. Ewes were classified as affected or not by subclinical mastitis within a lactation based on i) a positive culture in one of the test-days and ii) more than 750,000 somatic cells. Generalized linear mixed models were fitted to assess the significance of LGB genotypes on MTB and MTC. The LGB genotypes significantly affected MTB (p=0.0387), and showed a tendency on MTC (p=0.1104). Least square means showed that in the analysis for MTB, individuals with genotypes BB and AB had a higher frequency of subclinical mastitis. Moreover, the least square differen…

Veterinary medicinedairy goatsmilkbiologyIncidence (epidemiology)Animal Breeding and Genomicsmedicine.diseaseMastitisSubclinical mastitis Molecular marker b-lactoglobulin SheepAnimal sciencemedicine.anatomical_structureLactationGenotypemedicinebiology.proteinWIASAnimal Science and ZoologyFokkerij en GenomicaSubclinical mastitislcsh:Animal cultureSheep breedsomatic-cell countBeta-lactoglobulinSomatic cell countlcsh:SF1-1100
researchProduct

Genetic relatedness among environmental, clinical, and diseased-eel Vibrio vulnificus isolates from different geographic regions by ribotyping and ra…

1998

ABSTRACT Genetic relationships among 132 strains of Vibrio vulnificus (clinical, environmental, and diseased-eel isolates from different geographic origins, as well as seawater and shellfish isolates from the western Mediterranean coast, including reference strains) were analyzed by random amplified polymorphic DNA (RAPD) PCR. Results were validated by ribotyping. For ribotyping, DNAs were digested with Kpn I and hybridized with an oligonucleotide probe complementary to a highly conserved sequence in the 23S rRNA gene. Random amplification of DNA was performed with M13 and T3 universal primers. The comparison between ribotyping and RAPD PCR revealed an overall agreement regarding the high l…

Vibrio vulnificusApplied Microbiology and Biotechnologylaw.inventionRibotypingFish DiseaseslawAnimalsHumansSeawaterRibosomal DNAPolymerase chain reactionPhylogenyShellfishVibrioGeneticsGenetic diversityEelsEcologybiologyMediterranean RegionFishesGenetic Variationbiology.organism_classificationRAPDBacterial Typing TechniquesRandom Amplified Polymorphic DNA TechniqueRNA Ribosomal 23SEnvironmental and Public Health MicrobiologyGenetic markerVibrio InfectionsRestriction fragment length polymorphismDNA ProbesWater MicrobiologyFood ScienceBiotechnologyApplied and environmental microbiology
researchProduct

Vitamin C as a promoter of γδ T cells

2020

none

Vitamin CChemistrybusiness.industryT-LymphocytesT cellCommentImmunologyReceptors Antigen T-Cell gamma-deltaAscorbic AcidAscorbic acidMolecular biologyInfectious DiseasesText miningmedicine.anatomical_structureAntigenCorrespondencemedicineImmunology and AllergyLymphocytesPromoter Regions GeneticReceptorbusinessBiomarkersCellular & Molecular Immunology
researchProduct

2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism

2014

ACS : acute coronary syndrome AMPLIFY : Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-line Therapy aPTT : activated partial thromboplastin time b.i.d. : bis in diem (twice daily) b.p.m. : beats per minute BNP : brain natriuretic peptide BP : blood pressure CI : confidence interval CO : cardiac output COPD : chronic obstructive pulmonary disease CPG : Committee for Practice Guidelines CRNM : clinically relevant non-major CT : computed tomographic/tomogram CTEPH : chronic thromboembolic pulmonary hypertension CUS : compression venous ultrasonography DSA : digital subtraction angiography DVT : deep vein thrombosis ELISA : enzyme-linked immunosorben…

Vitamin KVasodilator AgentsAdministration OralChest pain; Diagnosis; Dyspnoea; Guidelines; Heart failure; Hypotension; Pulmonary embolism; Shock; Thrombolysis; Treatment-Anticoagulation; Venousthrombosis; Administration Oral; Algorithms; Anticoagulants; Biomarkers; Chronic Disease; Clinical Laboratory Techniques; Diagnostic Imaging; Embolectomy; Endovascular Procedures; Female; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; Heart Failure; Home Care Services; Humans; Hypertension Pulmonary; Long-Term Care; Neoplasms; Pregnancy; Pregnancy Complications Cardiovascular; Prognosis; Pulmonary Embolism; Risk Factors; Vasoconstrictor Agents; Vasodilator Agents; Vitamin K; Cardiology and Cardiovascular MedicineEmbolectomyCardiovascularChest painPregnancyRisk FactorsNeoplasmsDiagnosisVasoconstrictor AgentsSocieties MedicalEndovascular ProceduresShockGeneral MedicinePulmonaryPrognosisThrombosisThrombolysisHome Care ServicesPulmonary embolismEuropeVenous thrombosismedicine.veinPractice Guidelines as TopicAdministrationHypertensionCardiologyApixabanFemaleRadiologyHypotensionCardiology and Cardiovascular MedicineAlgorithmsmedicine.drugOralDiagnostic Imagingmedicine.medical_specialtypumonary hypertensionmedicine.drug_classHypertension PulmonaryPregnancy Complications CardiovascularCardiologyMEDLINELow molecular weight heparin610 Medicine & healthHeart failureGuidelinesInferior vena cavaFibrin Fibrinogen Degradation ProductsText miningFibrinolytic AgentsInternal medicineDyspnoeamedicineHumansIntensive care medicinebusiness.industryClinical Laboratory TechniquesPulmonary embolismAnticoagulantsTreatment-Anticoagulationmedicine.diseasePulmonary hypertensionLong-Term CarePregnancy ComplicationsVenousthrombosisHeart failureChronic DiseasebusinessBiomarkers
researchProduct